Online Media Kit


March 16, 2022 | Times LIVE (South Africa)

More HIV prevention options for SA women as vaginal ring approved

The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women. More »


February 26, 2022 | The East African (Kenya)

Young women prefer vaginal ring to daily oral pill for HIV prevention

Given a choice between two HIV prevention products, most adolescent girls and young women who had used both products while participating in the REACH study chose the monthly dapivirine ring. More »


January 26, 2021 | World Health Organization

WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection

WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »

Media Highlights

August 23, 2020 | Die PTA in Der Apotheke (Germany)

Vaginalring reduziert Infektionsrate mit HIV um 35 Prozent

A vaginal ring containing dapivirine received a positive recommendation from the European Medicines Agency. More »

August 22, 2020 | The Independent (Uganda)

Uganda listed among first countries to benefit from vaginal ring rollout

Uganda is among the first countries that will benefit from the roll out of the vaginal ring used in prevention against HIV. More »

August 21, 2020 | Science Africa (Kenya)

Vaginal Ring to Reduce HIV Risk

The monthly dapivirine vaginal ring would provide women with the first discreet, long-acting HIV prevention option. More »

August 19, 2020 | Making Waves

Let’s talk about the dapivirine vaginal ring

The positive opinion on the dapivirine ring is a big step forward in expanding prevention methods available for cisgender women. More »

August 18, 2020 | TheBodyPro

A Vaginal Ring to Prevent HIV Was Given a Positive Opinion by a European Drug Regulator. Here’s What You Need to Know About It.

TheBodyPro interviewed IPM's Zeda Rosenberg and AVAC's Manju Chatani about the dapivirine ring and the next steps needed to get it into the hands of women. More »